CLINICAL TRIALS PROFILE FOR MERIDIA
✉ Email this page to a colleague
All Clinical Trials for Meridia
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00234832 ↗ | A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients | Completed | Abbott | Phase 3 | 2003-01-01 | The purpose of the study was to determine the long-term effect of sibutramine treatment on cardiovascular outcomes in overweight and obese patients at risk of a cardiovascular event. |
NCT00234988 ↗ | A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects. | Completed | Abbott | Phase 4 | 2004-06-01 | The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects. |
NCT00261911 ↗ | A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. | Completed | Abbott | Phase 3 | 2000-07-01 | The purpose of this study is to assess the effectiveness of sibutramine on weight loss, reduction in body size and improvement in metabolic risk factors and safety in obese adolescents. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Meridia
Condition Name
Clinical Trial Locations for Meridia
Trials by Country
Clinical Trial Progress for Meridia
Clinical Trial Phase
Clinical Trial Sponsors for Meridia
Sponsor Name